Nephrology Doctors in Wenatchee, WA Accepting Medicare

6 Nephrology doctors found. Showing 1 - 6

Andy K Prasad, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711

Neil R Hannigan, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711

Mabel Amelia Bodell, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711

David M Jaecks, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711

Luis Bent-shaw, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711

Joseph Anzalone, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711

News Archive

St. Jude Medical reaches settlement agreement with DOJ over post-market study matter in Boston

St. Jude Medical, Inc., a global medical device company, today issued the following statement regarding a settlement agreement reached with the U.S. Department of Justice (DOJ) regarding a previously disclosed 2005 investigation in Boston related to an industry-wide review of post-market studies and registries:

Researchers develop new electrophoretic method for detecting MIRCERA and EPO in blood

Austrian researchers have successfully developed a new electrophoretic method for detecting MIRCERA® and other erythropoietins (EPO) in the blood. The technique, using SARCOSYL-PAGE, has specifically enhanced sensitivity for MIRCERA, but does not alter the performance characteristics of SDS-PAGE for detecting other EPOs.

Key international experts to attend major European bone congress in Bourse, France

Key international experts in the bone field are to be featured speakers and session leaders at the upcoming European Congress on Osteoporosis & Osteoarthritis (IOF-ECCEO12). As the major European bone event of the year, IOF-ECCEO12 will present the latest research and clinical advances in the bone field.

Protein called cyclin D1 disrupts BRCA1's normal role as a cancer inhibitor

For about a decade, scientists have recognized that many cases of hereditary breast cancer result from a mutation of a specific gene called BRCA1, which, in its normal state, helps keep tumor formation in check. About five to 10 percent of breast cancer cases are linked to genetic miscues, about half of which are linked to BRCA1.

Hydraulic fracturing is harmful to infants health, study states

A new study published in Science Advances reveals that infants born to mothers who live within 2 miles of a hydraulic fracturing site or fracking site have increased health risks.

Read more Medical News

› Verified 7 days ago